Smallpox revaccination of 21000 first responders in Israel: lessons learned

References 

1. Gerichter CH. Preparation of vaccine against smallpox in chorioallantoic membranes of chicken embryos. Jerusalem, Israel: Public Health Services, Israeli Ministry of Health; 1966;p. 36–41
2. Rotz LD, Dotson DA, Damon IK, Becher JA; Advisory Committee on Immunization Practices. Vaccinia (smallpox) vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001. MMWR Recomm Rep 2001;50(RR-10):1–25.
3. Centers for Disease Control and Prevention (CDC). Supplemental recommendations on adverse events following smallpox vaccine in the pre-event vaccination program: recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 2003;52:282–4 and 52(RR-7):1–16.
4. Somekh E, Smetana Z, Tanay A, Dalal I, Babai I, Mendelson E. Determination of immunity to vaccinia virus using diluted, inactivated vaccinia vaccine solution for skin testing. Vaccine. 2004;23:321–324
   • MEDLINE
   • CrossRef
5. Gerichter CH, Borusch D, Silberstein W. Some biological and technical aspects of smallpox vaccination. Jerusalem, Israel: Public Health Services, Israeli Ministry of Health; 1966;p. 30–35
6. Frey SE, Newman FK, Yan L, Belsche RB. Response to smallpox vaccine in persons immunized in the distant past. JAMA. 2003;289:3295–3299
   • CrossRef
7. Grabenstein JD, Winkenwerder W. US military smallpox vaccination program experience. JAMA. 2003;289:3278–3282
   • CrossRef
8. Balicer R, Davidovitch N, Huerta M, Cohen D, Grotto I. Smallpox vaccination techniques: considerations and unresolved issues. Harefuah. 2005;144:51–5669
   • MEDLINE
9. Balicer R, Grotto I, Huerta M, Leventhal A, Zach R, Yahalom V, et al. Beveled needle technique is not associated with low ‘take’ rates in Israeli smallpox revaccination campaign. Human Vaccines. 2005;1:224–227
   • MEDLINE
   • CrossRef
10. Frey SE, Couch RB, Tacket CO, Treanor JJ, Wolff M, Newman FK, et al. Clinical responses to undiluted and diluted smallpox vaccine. N Engl J Med. 2002;346:1265–1274
    • CrossRef
11. Couch RB, Winokur P, Edwards KM, Black S, Atmar RL, Stapleton JT, et al. Reducing the dose of smallpox vaccine reduces vaccine-associated morbidity without reducing vaccination success rates or immune responses. J Infect Dis. 2007;195:826–832
    • MEDLINE
    • CrossRef
12. Nishiura H, Schwehm M, Eichner M. Still protected against smallpox? Estimation of the duration of vaccine-induced immunity against smallpox. Epidemiology. 2006;17:576–581
    • MEDLINE
    • CrossRef
13. Nishiura H, Eichner M. Estimation of the duration of vaccine induced residual protection against severe and fatal smallpox based on secondary vaccination failure. Infection. 2006;34:241–246
    • MEDLINE
    • CrossRef
14. Orr N, Forman M, Marcus H, Lustig S, Paran N, Grotto I, et al. Clinical and immune responses after revaccination of Israeli adults with the Lister strain of vaccinia virus. J Infect Dis. 2004;190:1295–1302
    • MEDLINE
    • CrossRef